The PSMA expression levels are directly correlated to androgen independence, metastasis, and PCa progression [10]; therefore, PSMA is an attractive target for diagnosis and therapy of metastasised prostate cancer. The gene discussed is FOLH1; the disease is posterior cortical atrophy.